Full Description
CVD, or cardiovascular disease, is a general term that describes a disease of the heart or blood vessels. It is one of the most common causes of death.
Statins are a group of medicines that can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. LDL cholesterol of often referred to as 'bad cholesterol', and statins reduce its production in the liver. Having a high level of LDL is potentially dangerous as it can lead to hardening and narrowing of the arteries (NHS).
Comprising nearly 1000 pages, this book is a comprehensive guide to the latest advances in statin therapy and its clinical application for cardiovascular disease.
Divided into 29 sections, the text begins with clinical aspects of CVD, dyslipidemia (the imbalance of lipids such as cholesterol), and the use of statins for treatment.
The next sections provide detailed discussion on the use of statins for different types of CVD, including coronary artery disease, hypertension, heart failure, arrhythmia, stroke, and more.
The following chapters cover statin use for other systemic diseases such as obesity, kidney disease, diabetes, ocular disorders, skin conditions and many more.
The book concludes with an insight into future therapies, with emphasis on PCSK9 inhibitors, a new treatment for lowering cholesterol in the blood.
Contents
Section I: Clinical
Section II: Statins and CAD
Section III: Statins and Hypertension
Section IV: Statins in Heart Failure
Section V: Statins in Arrhythmia
Section VI: Statins in Aortic Disease
Section VII: Statin and Stroke
Section VIII: Statins and Carotid Artery Disease
Section IX: Peripheral Vascular Disease
Section X: Statins in Reno Vascular Disease
Section XI: Statins in Diabetes
Section XII: Statins and Obesity
Section XIII: Statins and Kidney
Section XIV: Echocardiographic Evaluation of Statin Effect and Outcome
Section XV: Aortic Atherosclerotic Statin Effect Evaluation
Section XVI: Statin Effect Evaluation in Renovascular Disease
Section XVII: Nuclear Imaging in Vascular Atherosclerosis
Section XVIII: Nutrition and Dyslipidemia
Section XIX: Statins and Pediatric
Section XX: Statins and Eyes
Section XXI: Statins and Skin
Section XXII: Statins and Pulmonary disorders
Section XXIII: Atorvastatin and CVD Prevention
Section XXIV: Rosuvastatin and CVD Prevention
Section XXV: Systemic Inflammatory Response Syndrome
Section XXVI: Dyslipidemia, Yoga & Statin Therapy
Section XXVII: Statins in Cardio Oncology
Section XXVIII: Beyond Statins
Section XXIX: Future Directions
